Cost-effectiveness of leg bypass versus endovascular therapy for critical limb ischemia a systematic review
Critical limb ischemia (CLI) is a severe form of peripheral arterial disease (PAD) marked by ischemic rest pain, tissue loss, or gangrene. CLI is associated with significant morbidity, mortality, and resource utilization. Patients can be treated with revascularization, either surgical or endovascula...
Main Authors: | , , , |
---|---|
Corporate Authors: | , |
Format: | eBook |
Language: | English |
Published: |
Washington, DC
Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service
March 2019, 2019
|
Series: | Evidence systhesis program
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | Critical limb ischemia (CLI) is a severe form of peripheral arterial disease (PAD) marked by ischemic rest pain, tissue loss, or gangrene. CLI is associated with significant morbidity, mortality, and resource utilization. Patients can be treated with revascularization, either surgical or endovascular. To help clinicians, patients, and policymakers decide between surgery-first and endovascular-first approaches in patients with CLI, we were asked to conduct a systematic review of the literature |
---|---|
Physical Description: | 1 PDF file (vi, 63 pages) illustrations |